Skip to main content
OpenTrials
Completed

NCT Number: NCT03851393

Validation of Peptest™ for the Detection of Reflux in Cough

Chronic cough is a common presenting problem which has a significant impact on quality of life. Gastro-oesophageal reflux (GOR) is a common cause of chronic cough and reflux of stomach contents into the airways has been implicated in the pathogenesis of a number of respiratory diseases. Clinical history in patients with suspected reflux can aid in the diagnosis but traditional investigations for GOR including 24hr oesophageal pH monitoring or endoscopy are not reliable diagnostic tools since the reflux may be non acidic.

The detection of pepsin in the sputum, saliva or bronchial biopsy has been found to be an accurate marker of reflux into the airways. Pepsin is solely produced by parietal cells in the stomach. The presence of pepsin in the upper airways therefore indicates reflux. Studies have demonstrated that pepsin was frequently found in laryngeal biopsies and sputum of patients with signs and symptoms of airways reflux and that Nissen fundoplication resulted in a decrease in pepsin detection alongside an improvement in symptoms. The Peptest™ lateral flow device has been shown to be effective in the detection of pepsin in sputum and saliva of patients with chronic cough and gastro-oesophageal reflux. The investigators have detected pepsin in expectorated saliva during episodes of cough, apparently supporting a diagnosis of airways reflux. Critics, however, have suggested that the act coughing itself is responsible for the reflux.

This study aims to identify if cough induced by inhaled citric acid in healthy adult volunteers leads to detectable pepsin in expectorated saliva.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hull Clinical Trials Unit, Respiratory academic department

Cottingham, Yorkshire, HU16 5JQ, United Kingdom

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A negative score for airway reflux (HARQ score <13).
  • Provision of informed consent.

Exclusion criteria

  • Participants with a positive score for airway reflux (HARQ score >13).
  • Chronic respiratory disease.
  • Acute gastro-respiratory illness at the time of the study.
  • Participants who will be physically unable to undergo sputum collection or cough induction.
  • Those who are unwilling to undergo cough challenge and induction of cough.
  • Smoking or consumption of food, caffeinated or carbonated beverages for 30 minutes prior to sample collection.

Treatment and study plan

Induction of cough with inhaled citric acid

Other

perform artificially induced cough by inhalation of citric acid at various strengths

Peptest™ analysis of saliva pepsin

Procedure

collect patient saliva for analysis of pepsin levels

Peptest™

Diagnostic Test

The Peptest™ lateral flow device

Primary outcomes

  1. level of pepsin in saliva following a citric acid cough challenge

    Time frame: 3 months

    detecting the levels of pepsin in saliva following Citric acid induced cough

Secondary outcomes

  1. normal range of saliva pepsin

    Time frame: 3 months

    record normal range of saliva pepsin following citric acid cough challenge

Sponsors and collaborators

Lead sponsor

Hull University Teaching Hospitals NHS Trust

Other Gov

Registry information

Official study title

Validation of Peptest™ for the Detection of Reflux in Cough; Induction of Cough in Healthy Volunteers

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Feb 22, 2019
Registry last updated
Jul 15, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.